Fact CheckerSign in

NCT06132581Recruiting

Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression

Source: ClinicalTrials.gov · Last updated 31 Aug 2026

Brief summary (registry, in English)

Anhedonia, the inability to seek-out and experience pleasure, is a common symptom in depression that predicts treatment-resistance and is sometimes exacerbated by first-line antidepressants. In our previous research, we found that anhedonia decreases goal-directed behavior and its related neural activity. In this study, we will investigate target engagement from five-consecutive days of stimulation for participants that are within a unipolar major depressive episode and also have high symptoms of anhedonia.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
72 (estimated)
First submitted
7 Nov 2023
Start date
24 Jan 2024
Primary completion date
31 Jul 2027
Lead sponsor
Florida State University
Diseases
Depression
NCT number
NCT06132581

What you commit to

  • Study type: Interventional
  • Planned participants: 72
  • From 24 Jan 2024 to the primary completion date, 31 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior brain surgery

Other illness

  • Neurological disorders and conditions including, but not limited to history of epilepsy; seizures, except childhood febrile seizures; dementia; history of stroke; Parkinson's disease, multiple sclerosis, cerebral aneurysm; brain tumors
  • Medical or neurological illness or treatment for a medical disorder that could interfere with study participation. For example, unstable cardiac disease, HIV/AIDS, malignancy, liver or renal impairment
  • Any brain devices/implants including cochlear implants and aneurysm clips, cardiac pacemaker, or any other implanted electronic device
  • History of current traumatic brain injury
  • Current severe substance use disorder
  • DSM-V diagnosis of present moderate or severe substance use disorder or alcohol use disorder, and past severe substance use disorder or alcohol use disorder, or psychotic disorder within the last 12 months

Other

  • ADHD (currently under treatment)
  • Pregnancy (for females)
  • Claustrophobia
  • Based on the use of MRI, additional exclusion/inclusion criteria are considered. Note that many contraindications for stimulation are common with MRI and thus are not repeated. Participants must not have metal in the body that is ferrous, will be required to remove all jewelry, must not have tattoos on the face or neck, must refrain from wearing metal in clothing (underwire) or active gear (possibility of metallic microparticle technology), must not be a metal worker or have an eye injury involving metal.
  • Anything that in the opinion of the investigator would place the participant at increased risk or preclude the participant's full compliance with or completion of the study

Who the study is looking for

  • Between the ages of 18 and 65
  • Able to provide informed consent
  • Have normal to corrected vision
  • Willing to comply with all study procedures and be available for the duration of the study
  • Speak and understand English
  • Mild suicide risk as determined by the Hamilton Depression Rating Scale (HAM-D; less than 3 for the suicidality item) and non-existent or mild risk according to the Depression Symptom Index Suicidality Subscale (DSI-SS).
  • Patient Health Questionnaire (PHQ-8) greater than or equal to 8 prior to the first session
  • Snaith Hamilton Pleasure Scale (SHAPS) greater than 33 at the first session
  • A diagnosis of major depressive disorder on the Mini International Neuropsychiatric Interview for the DSM-V (MINI)

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Florida State University
Coordinator of this site? Confirm its status
TallahasseeUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.